The Expected Covid Cliff Is Here For Pfizer — Company Calls For Steep 2023 Declines

The Expected Covid Cliff Is Here For Pfizer — Company Calls For Steep 2023 Declines · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

Pfizer called for steep declines this year from its Covid vaccine and antiviral pill, but Pfizer stock reversed higher Tuesday.

Recommended Stories